Highlights Newsletter 4

This newsletter presents you the following key sessions:

1. Podcast with dr. Antonio D'Alessio about real-world use of atezolizumab plus bevacizumab in patients with
    hepatocellular carcinoma and Child-Pugh A and B cirrhosis

2. Combination of docetaxel, cisplatin and 5-FU as a new standard neoadjuvant treatment for oesophageal
    squamous cell cancer

3. Addition of durvalumab to gemcitabine-cisplatin significantly improves outcomes in first-line advanced
    biliary tract cancer

4. Lenvatinib plus transarterial chemoembolisation improves clinical outcomes in patients with advanced
    hepatocellular carcinoma

5. Meaningful objective response rate with trastuzumab deruxtecan in HER2-associated advanced colorectal
    cancer